USPTO 2015–2025 USPTO PatentsView US Corporation

Rhode Island Hospital, A Lifespan-partner

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

7
Total patents granted
10
CPC technology areas
19.1
Avg claims per patent
+33%
5-year filing velocity

The verdict

Rhode holds 7 US patents across 10 technology areas, rank #37,244 of 50,000 tracked assignees.

#37,244
of 50,000 US assignees by volume
Top 14%
by Innovation Score (49.9/100)
19.1
avg claims per patent
+33%
filing velocity, last 5 yrs

Portfolio overview

Rhode Island Hospital, A Lifespan-partner has been granted 7 US utility patents between 2016 and 2025, placing Rhode Island Hospital, A Lifespan-partner at rank #37,244 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Rhode Island Hospital, A Lifespan-partner is one of the more focused assignees in the PatentsView dataset. By volume, Rhode sits between Research Intertional, Inc. (7 patents, rank #37,240) and Riobel Inc. (7 patents, rank #37,248) - the closest US assignees by grant volume. The composite Innovation Score of 49.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 3 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Rhode Island Hospital, A Lifespan-partner's 19.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Rhode Island Hospital, A Lifespan-partner against peers pursuing similar technology classes.

Who files at Rhode's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Rhode holds 7 patents at rank #37,244, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Rhode

By rank, the assignees closest to #37,244 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Rhode's primary technology class.

Rhode's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

50 Top 14% higher than 86% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201620172019202220232025 1
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Rhode Island Hospital, A Lifespan-partner patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 14.3%
2017 1 14.3%
2019 1 14.3%
2022 1 14.3%
2023 2 28.6%
2025 1 14.3%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Growing

Where it ranks

Overall rank by patents

#37,244

Across all tracked assignees

Innovation Score

49.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Rhode Island Hospital, A Lifespan-partner hold?
Rhode Island Hospital, A Lifespan-partner holds 7 US granted patents filed between 2016 and 2025, spanning 10 technology areas.
What is Rhode Island Hospital, A Lifespan-partner's Innovation Score?
Rhode Island Hospital, A Lifespan-partner has an Innovation Score of 49.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Rhode Island Hospital, A Lifespan-partner focus on?
Rhode Island Hospital, A Lifespan-partner's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 6 patents. The company has filed patents in 10 CPC subclasses total.
Is Rhode Island Hospital, A Lifespan-partner's patent filing rate increasing or decreasing?
Rhode Island Hospital, A Lifespan-partner's recent filing velocity is +33% compared to the prior five-year period. The company is maintaining or growing its patent output.
What does claim depth mean for Rhode Island Hospital, A Lifespan-partner's patents?
Rhode Island Hospital, A Lifespan-partner's patents average 19.1 claims each. This falls within the standard range, providing solid legal coverage.
How is the Rhode Island Hospital, A Lifespan-partner patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Rhode's 7 grants land it in the top 14% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Rhode ranks #37,244 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.